Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.
Sirenko M. et al, (2025), Cell Stem Cell
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.
Li R. et al, (2024), Sci Transl Med, 16
Implementing human bone marrow organoids to interrogate microenvironmental influences on the efficacy of blood cancer immunotherapies
Wong ZC. et al, (2024), CANCER RESEARCH, 84
RUX-AZA Response in AP/BP-MPN Is Driven By Release of the Differentiation Block in Mutant HSPCs: A Single-Cell Multi-Omic Analysis of Responders on the Phase Ib Phazar Study
Brierley CK. et al, (2024), BLOOD, 144, 3146 - 3147
Chromothripsis orchestrates leukemic transformation in blast phase MPN through targetable amplification of DYRK1A.
Brierley CK. et al, (2023), bioRxiv
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
Rodriguez-Meira A. et al, (2023), Nat Genet, 55, 1531 - 1541
A tale of two alleles: TP53 and transformation in MPNs.
Brierley C. and Psaila B., (2022), Blood, 139, 3567 - 3568
Cross-Talk between Hematopoietic Cells and Fibroblast Subsets Drives Inflammation and Remodelling of the Bone Marrow Microenvironment in Myeloproliferative Neoplasms
Li R. et al, (2022), BLOOD, 140, 1091 - 1092
Molecular Characterisation of Participants in the Phazar Trial Reveals Prognostic Impact of Mutations in Advanced-Phase-MPN
Brierley CK. et al, (2020), BLOOD, 136
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes.
Brierley CK. et al, (2020), Cancer, 126, 4735 - 4743
A NOVEL IN VITRO PLATFORM FOR THE PRIORITISATION AND VALIDATION OF INHIBITORS OF BONE MARROW FIBROSIS USING HUMAN BONE MARROW (BM) STROMAL CELLS
COLOMBO M. et al, (2020), HemaSphere, 4, 1 - 1168
Single-cell sequencing in hematology.
Brierley CK. and Mead AJ., (2020), Curr Opin Oncol, 32, 139 - 145
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE).
Sharrack B. et al, (2020), Bone Marrow Transplant, 55, 283 - 306
Sugar thieves and addicts: nutrient subversion in JAK2 MPNs.
Brierley CK. and Psaila B., (2019), Blood, 134, 1778 - 1780
The effects of monoclonal anti-CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia.
Brierley CK. et al, (2019), Transfusion, 59, 2248 - 2254
Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies.
Brierley CK. et al, (2019), Br J Haematol, 184, 547 - 557